Long-Term Changes in Post-Stroke Depression, Emotional Incontinence, and Anger
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Long-term changes in post-stroke depression (PSD), post-stroke emotional incontinence (PSEI), and post-stroke anger (PSA) have rarely been studied. Methods This is a sub-study of EMOTION, a randomized, placebo-controlled trial, that examined the efficacy of escitalopram on PSD, PSEI, and PSA in patients with stroke. We interviewed patients at the long-term period (LTP) using predefined questionnaires: Montgomery-Åsberg depression rating scale (MADRS) for PSD, modified Kim’s criteria for PSEI, and Spielberger trait anger scale for PSA. Additionally, the ENRICHD Social Support Instrument (ESSI) for the social support state and the modified Rankin Scale (mRS) were measured. We investigated the changes in and factors behind PSD, PSEI, and PSA at LTP. Results A total of 222 patients were included, and the median follow-up duration was 59.5 months (interquartile range, 50 to 70). Compared to the data at 6 months post-stroke, the prevalence of PSEI (11.7% at 6 months, 6.3% at LTP; P=0.05) and mean anger score (21.62, 16.24; P<0.01) decreased, while the prevalence of PSD (35.6%, 44.6%; P=0.03) and mean MADRS (6.16, 8.67; P<0.01) increased at LTP. ESSI was associated with PSD and PSA, but not with PSEI. The effect of the baseline National Institutes of Health Stroke Scale score on PSD decreased over time. The effect of low social support on PSD was greater than that of mRS at LTP. Conclusions The prevalence and degree of PSD significantly increased, while those of PSEI and PSA decreased at LTP. PSD in this stage appeared to be more closely associated with a lack of social support than patients' physical disabilities.
Abstract
Background and Purpose Long-term changes in post-stroke depression (PSD), post-stroke emotional incontinence (PSEI), and post-stroke anger (PSA) have rarely been studied. Methods This is a sub-study of EMOTION, a randomized, placebo-controlled trial, that examined the efficacy of escitalopram on PSD, PSEI, and PSA in patients with stroke. We interviewed patients at the long-term period (LTP) using predefined questionnaires: Montgomery-Åsberg depression rating scale (MADRS) for PSD, modified Kim’s criteria for PSEI, and Spielberger trait anger scale for PSA. Additionally, the ENRICHD Social Support Instrument (ESSI) for the social support state and the modified Rankin Scale (mRS) were measured. We investigated the changes in and factors behind PSD, PSEI, and PSA at LTP. Results A total of 222 patients were included, and the median follow-up duration was 59.5 months (interquartile range, 50 to 70). Compared to the data at 6 months post-stroke, the prevalence of PSEI (11.7% at 6 months, 6.3% at LTP; P=0.05) and mean anger score (21.62, 16.24; P<0.01) decreased, while the prevalence of PSD (35.6%, 44.6%; P=0.03) and mean MADRS (6.16, 8.67; P<0.01) increased at LTP. ESSI was associated with PSD and PSA, but not with PSEI. The effect of the baseline National Institutes of Health Stroke Scale score on PSD decreased over time. The effect of low social support on PSD was greater than that of mRS at LTP. Conclusions The prevalence and degree of PSD significantly increased, while those of PSEI and PSA decreased at LTP. PSD in this stage appeared to be more closely associated with a lack of social support than patients' physical disabilities.
참고문헌 (29)
- Kim JS, "Inability to control anger or aggression after stroke", Neurology, 58, pp.1106~1108 (2002)
- Kim JS, "Poststroke depression and emotional incontinence : correlation with lesion location", Neurology, 54, pp.1805~1810 (2000)
- Jong S. Kim, "Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms", 대한뇌졸중학회지, 18(3), pp.244~255 (2016), 대한뇌졸중학회
- Hackett ML, "Part I : frequency of depression after stroke : an updated systematic review and meta-analysis of observational studies", Int J Stroke, 9, pp.1017~1025 (2014)
- Towfighi A, "Poststroke depression : a scientific statement for healthcare professionals from the American Heart Association", American Stroke Association, 2017, pp.48, e30~e43
- Werheid K, "A two-phase pathogenetic model of depression after stroke", Gerontology, 62, pp.33~39 (2015)
- Kim JS, "Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study", Lancet Psychiatry, 4, pp.33~41 (2017)
- Montgomery SA, "A new depression scale designed to be sensitive to change", Br J Psychiatry, 134, pp.382~389 (1979)
- Kearns NP, "A comparison of depression rating scales", Br J Psychiatry, 141, pp.45~49 (1982)
- Kang HJ, "Comparative validity of depression assessment scales for screening poststroke depression", J Affect Disord, 147, pp.186~191 (2013)
- Eun-Jae Lee, "Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline Depression", 대한뇌졸중학회지, 20(2), pp.258~267 (2018), 대한뇌졸중학회
- Brott T, "Measurements of acute cerebral infarction : a clinical examination scale", Stroke, 20, pp.864~870 (1989)
- Farrell B, "The United Kingdom transient ischaemic attack(UK-TIA)aspirin trial : final results", J Neurol Neurosurg Psychiatry, 54, pp.1044~1054 (1991)
- Rao N, "The clinical pharmacokinetics of escitalopram", Clin Pharmacokinet, 46, pp.281~290 (2007)
- Mitchell PH, "A short social support measure for patients recovering from myocardial infarction : the ENRICHD Social Support Inventory", J Cardiopulm Rehabil, 23, pp.398~403 (2003)
- ENRICHD Investigators, "Enhancing recovery in coronary heart disease(ENRICHD) : baseline characteristics", Am J Cardiol, 88, pp.316~322 (2001)
- Ayerbe L, "Natural history, predictors, and associations of depression 5 years after stroke: the South London Stroke Register", Stroke, 42, pp.1907~1911 (2011)
- Ayerbe L, "The longterm outcomes of depression up to 10 years after stroke : the South London Stroke Register", J Neurol Neurosurg Psychiatry, 85, pp.514~521 (2014)
- Ki M, "Delays in depression treatment among Korean population", Asia Pac Psychiatry, 6, pp.414~424 (2014)
- Turvey CL, "Cultural differences in depression-related stigma in late-life: a comparison between the USA, Russia, and South Korea", Int Psychogeriatr, 24, pp.1642~1647 (2012)
- Organization for Economic Cooperation, "Health at a glance 2015: OECD indicators" (2015), OECD
- Chuang CS, "Hyperlipidemia, statin use and the risk of developing depression:a nationwide retrospective cohort study", Gen Hosp Psychiatry, 36, pp.497~501 (2014)
- Valkanova V, "Vascular risk factors and depression in later life : a systematic review and meta-analysis", Biol Psychiatry, 73, pp.406~413 (2013)
- House A, "Emotionalism after stroke", BMJ, 298, pp.991~994 (1989)
- Andersen G, "Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission", Stroke, 25, pp.1050~1052 (1994)
- Kim JM, "Associations of serotonergic genes with poststroke emotional incontinence", Int J Geriatr Psychiatry, 27, pp.799~806 (2012)
- Kim JS, "Post-stroke emotional incontinence after small lenticulocapsular stroke : correlation with lesion location", J Neurol, 249, pp.805~810 (2002)
- Murai T, "Neuroimaging of serotonin transporters in poststroke pathological crying", Psychiatry Res, 123, pp.207~211 (2003)
- Leykin Y, "The effect of depression on the decision to join a clinical trial", J Consult Clin Psychol, 85, pp.751~756 (2017)